ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Arvelle Therapeutics Netherlands B.V

Arvelle Therapeutics Netherlands B.V is a converted/closed company incorporated on 9 January 2020 with the registered office located in . Arvelle Therapeutics Netherlands B.V was registered 5 years ago.
Status
Converted/closed
Company No
FC037032
Overseas company
Age
5 years
Incorporated 9 January 2020
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Exempt
FC companies are not required to submit this
Accounts
Not Submitted
Awaiting first accounts
Learn more about Arvelle Therapeutics Netherlands B.V
Contact
Address
36 Zuidplein
Amsterdam
Noord-Holland
1077xv
Netherlands
Same address since incorporation
Telephone
Unreported
Email
Unreported
Website
Unreported
See All Contacts
People
Officers
4
Shareholders
-
Controllers (PSC)
-
Gerard Harm Scheenstra
Director • Business Consultant • Dutch • Lives in Netherlands • Born in Mar 1959
Serena Francesca Lina Zucchetta
Director • Executive Director • Italian • Lives in Italy • Born in Jul 1968
Jan Peije Verhoeff
Director • Business Consultant • Dutch • Lives in Netherlands • Born in Aug 1953
Silvestro Camerini
Director • Pharma Chief And Financial Officer • Italian • Lives in Italy • Born in Mar 1961
See Key People
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
See All Shareholders, PSCs & Group Structure
Mutual Companies
No mutual companies found
See All Mutual Companies
Financials
Net Assets, Total Assets & Total Liabilities (2019–2019)
Period Ended
31 Dec 2019
For period 31 Dec ⟶ 31 Dec 2019
Traded for 12 months
Cash in Bank
£8.13K
Turnover
Unreported
Employees
Unreported
Total Assets
£65.01K
Total Liabilities
-£139.95K
Net Assets
-£74.94K
Debt Ratio (%)
215%
See 10 Year Full Financials
Latest Activity
Silvestro Camerini Appointed
4 Years Ago on 18 Feb 2021
Serena Francesca Lina Zucchetta Appointed
4 Years Ago on 18 Feb 2021
Serena Francesca Lina Zucchetta Appointed
4 Years Ago on 2 Feb 2021
Gregory Mark Weinhoff Resigned
4 Years Ago on 2 Feb 2021
Jan Peije Verhoeff Appointed
4 Years Ago on 2 Feb 2021
Gerard Harm Scheenstra Appointed
4 Years Ago on 2 Feb 2021
Silvestro Camerini Appointed
4 Years Ago on 2 Feb 2021
Stuart Peter Mulheron Appointed
4 Years Ago on 6 Jan 2021
Full Accounts Submitted
4 Years Ago on 6 Jan 2021
UK Establishment Changed
5 Years Ago on 30 Apr 2020
Get Alerts
Get Credit Report
Discover Arvelle Therapeutics Netherlands B.V's Credit Score, how much credit you can offer them, and how likely they are to repay you
See All Credit Score & Limits
Documents
Submitted on 25 May 2022
Submitted on 2 Mar 2021
Appointment of Silvestro Camerini as a person authorised to represent UK establishment BR022120 on 2 February 2021.
Submitted on 18 Feb 2021
Appointment of Silvestro Camerini as a director on 2 February 2021
Submitted on 18 Feb 2021
Appointment of Gerard Harm Scheenstra as a director on 2 February 2021
Submitted on 18 Feb 2021
Appointment of Jan Peije Verhoeff as a director on 2 February 2021
Submitted on 18 Feb 2021
Termination of appointment of Gregory Mark Weinhoff as a director on 2 February 2021
Submitted on 18 Feb 2021
Appointment of Serena Francesca Lina Zucchetta as a person authorised to represent UK establishment BR022120 on 2 February 2021.
Submitted on 18 Feb 2021
Appointment of Serena Francesca Lina Zucchetta as a director on 2 February 2021
Submitted on 18 Feb 2021
Full accounts made up to 31 December 2019
Submitted on 6 Jan 2021
Explore All Documents
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year
See All Charges & CCJs